PIP5K2 Alpha (PIP5K2A) Antibody (N-term) Blocking peptide

The synthetic peptide sequence used to generate the antibody was selected from the N-term region of human PIP5K2A. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

[Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha; Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha; phosphatidylinositol 5-phosphate 4-kinase type-2 alpha; phosphatidylinositol-5-phosphate 4-kinase type 2 alpha; 1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha; Diphosphoinositide kinase 2-alpha; PIP5KIII; Phosphatidylinositol 5-phosphate 4-kinase type II alpha; PI(5)P 4-kinase type II alpha; PIP4KII-alpha; PtdIns(4)P-5-kinase B isoform; PtdIns(4)P-5-kinase C isoform; PtdIns(5)P-4-kinase isoform 2-alpha]